What is the best management approach for a patient with myelomeningocele and Arnold Chiari malformation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Myelomeningocele with Arnold Chiari Malformation

Patients with myelomeningocele and Arnold Chiari II malformation require early surgical closure of the spinal defect, aggressive management of hydrocephalus as the primary intervention for symptoms, and selective posterior fossa decompression only for those who fail ventricular drainage optimization. 1, 2

Initial Surgical Management

Spinal Defect Closure

  • Close the myelomeningocele defect urgently within the first 24-48 hours of life to prevent infection and further neurological deterioration 1
  • This is the foundational intervention that must precede all other management decisions

Hydrocephalus Management - The Critical First Step

  • Hydrocephalus is present in nearly all patients with Chiari II malformation and must always be addressed first when any symptoms develop 1, 2
  • Place a ventriculoperitoneal shunt or perform external ventricular drainage as the initial intervention for symptomatic patients 2
  • Approximately 40% of symptomatic patients will have complete resolution of their Chiari II symptoms with ventricular drainage alone, making this the mandatory first-line treatment 2
  • Before considering posterior fossa decompression, ensure the shunt is functioning properly - shunt malfunction is a common cause of symptom recurrence 2

Diagnostic Evaluation

Imaging Requirements

  • Obtain complete MRI of both brain and spine to evaluate for hydrocephalus, syringomyelia, tethered cord, and the extent of hindbrain herniation 3, 4, 5
  • Arnold Chiari II malformation is found in 76% of myelomeningocele patients on MRI, with 44% having the more severe type II variant 5
  • Include sagittal T2-weighted sequences of the craniocervical junction to assess cerebellar tonsillar position and brainstem compression 4
  • Consider phase-contrast CSF flow studies to evaluate for CSF flow obstruction 4

Associated Conditions to Screen For

  • Syringomyelia occurs in approximately 50% of cases and may require specific intervention 1
  • Tethered spinal cord is present in 89% of patients and can contribute to neurological deterioration 5
  • Scoliosis develops in many patients and requires orthopedic evaluation 1, 6

Indications for Posterior Fossa Decompression

When to Proceed with Decompression

  • Only perform craniocervical decompression in the 60% of symptomatic patients who fail to improve after adequate ventricular drainage 2
  • Specific symptoms warranting consideration include: progressive lower cranial nerve dysfunction (dysphagia, stridor, apnea), severe neck pain unresponsive to shunt optimization, progressive upper extremity weakness, or worsening syringomyelia 1, 2

Surgical Technique Options

  • Either posterior fossa decompression alone or posterior fossa decompression with duraplasty may be utilized 3
  • Consider cerebellar tonsil reduction if significant syringomyelia is present 3

Timing Considerations

  • Urgent decompression is required for neonates with severe brainstem compression causing apnea, stridor, or aspiration 2
  • Elective decompression should be performed before severe deterioration occurs in patients with progressive but less critical symptoms 2

Outcomes and Follow-up

Expected Results

  • Clinical improvement occurs in approximately 92% of survivors after appropriate surgical management 2
  • Neck pain improves in one-third, sensorimotor deficits in two-fifths, and cranial nerve deficits in one-half of patients 1
  • Wait 6-12 months after initial surgery before considering repeat intervention for persistent syringomyelia, as delayed improvement is common 3

Long-term Monitoring Requirements

  • Overall mortality remains relatively high (10-15%) throughout the patient's life, primarily from cardiorespiratory arrest 2
  • Approximately 55% of patients require shunt revision during long-term follow-up 2
  • Monitor for cord tethering, which may require surgical release 2
  • 15% of patients require reoperation for symptom recurrence 2

Critical Pitfalls to Avoid

  • Never proceed directly to posterior fossa decompression without first optimizing ventricular drainage - this is the most common management error 1, 2
  • Do not assume shunt function is adequate based on stable ventricular size alone; slit-like ventricles can still indicate shunt malfunction 1
  • Recognize that intrinsic brainstem dysfunction cannot be surgically corrected; monitoring of vital functions may be the only option for some patients 1
  • Neonates have the worst prognosis with highest early mortality (approximately 5%), requiring particularly aggressive monitoring 2

References

Research

Primary and secondary management of the Chiari II malformation in children with myelomeningocele.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2013

Research

Surgical management of Chiari malformation type II.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2020

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Chiari Malformation with New Onset Diplopia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Central nervous system lesions and developmental scoliosis in myelomeningocele.

Zeitschrift fur Kinderchirurgie : organ der Deutschen, der Schweizerischen und der Osterreichischen Gesellschaft fur Kinderchirurgie = Surgery in infancy and childhood, 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.